^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Acute Lymphocytic Leukemia |
| Drug: | cyclophosphamide (Alkylating agent) + etoposide oral (Topoisomerase II inhibitor, DNA inhibitor) + clofarabine (DNA synthesis inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Acute Lymphoblastic Leukemia: Other Recommended regimens…Clofarabine alone 52, 53 or in combination (eg, clofarabine, cyclophosphamide, etoposide 54)
